Ophthalmology
Review: Hypertensive eye disease.
11 Mar, 2022 | 09:42h | UTCHypertensive eye disease – Nature Reviews Disease Primers (if the link is paywalled, try this one)
Infographic: Hypertensive eye disease (if the link is paywalled, try this one)
Commentary on Twitter
Get Primed on Hypertensive Eye Disease with our NEW PrimeView! FREE to download this week!#Hypertensionhttps://t.co/yL0WSHIJiH pic.twitter.com/HKPdssJGNR
— Nature Reviews Disease Primers (@DiseasePrimers) March 10, 2022
Degree of myopia and glaucoma risk: a dose-response meta-analysis.
8 Mar, 2022 | 08:32h | UTC
Systematic Review: Topical pharmacologic interventions versus placebo for epidemic keratoconjunctivitis.
4 Mar, 2022 | 08:46h | UTC
NICE Updated Guidance: Diagnosis and Management of Glaucoma.
18 Feb, 2022 | 08:39h | UTCGlaucoma: diagnosis and management – National Institute for Health and Care Excellence
Systematic Review: Vision impairment and cognitive decline among older adults.
18 Feb, 2022 | 08:19h | UTCVision impairment and cognitive decline among older adults: a systematic review – BMJ Open
Efficacy, durability, and safety of intravitreal Faricimab up to every 16 weeks for neovascular age-related macular degeneration: two randomized, double-masked, phase 3, non-inferiority trials.
15 Feb, 2022 | 08:29h | UTCEfficacy, durability, and safety of intravitreal faricimab up to every 16 weeks for neovascular age-related macular degeneration (TENAYA and LUCERNE): two randomised, double-masked, phase 3, non-inferiority trials – The Lancet (link to abstract – $ for full-text)
Commentary: Trials Show Promise for Intravitreal Faricimab in Retinal Disease – HealthDay
Consensus opinion for the management of soft tissue filler induced vision loss.
13 Feb, 2022 | 21:36h | UTC
Cohort study: Functional ophthalmic factors associated with extreme prematurity in young adults.
30 Jan, 2022 | 14:03h | UTCCommentary: Extremely Preterm Babies Have Higher Risk of Eye Problems as Adults – MedPage Today (free registration required)
Commentary on Twitter
This study found that extreme prematurity was associated with an increased prevalence of visual and ocular deficits. These deficits varied with, but were not fully explained by, neonatal retinopathy of prematurity status. @LondonEyeDoc https://t.co/dVdmJ0ZJz0
— JAMA Network Open (@JAMANetworkOpen) January 28, 2022
An artificial intelligence system can help predict myocardial infarction through retinal scans and minimal personal information.
26 Jan, 2022 | 01:44h | UTCNews release: Using the eye as a window into heart disease – University of Leeds
Original study: Predicting myocardial infarction through retinal scans and minimal personal information – Nature Machine Intelligence (link to abstract – $ for full-text)
Study shows that the retinal age gap might be a potential biomarker of aging linked to increased mortality risk.
20 Jan, 2022 | 09:04h | UTCRetinal age gap as a predictive biomarker for mortality risk – British Journal of Ophthalmology (link to abstract – $ for full-text)
News Release: Difference between retina’s biological age and person’s real age linked to heightened death risk – BMJ
Commentary on Twitter
Difference between retina’s biological age and person’s real age linked to heightened death risk finds @BMJ_Ophth study https://t.co/TNveo5E77D
— BMJ (@bmj_company) January 19, 2022
Grand Challenges in global eye health: a global prioritization process using Delphi method.
18 Jan, 2022 | 09:15h | UTCRelated podcast: Author interview
Commentary on Twitter
Roughly 2.2 billion people have vision impairment—yet 50% of sight loss is preventable.
In @LancetLongevity, Jacqueline Ramke & colleagues identify the key issues that must be addressed to improve global #EyeHealth in the context of an ageing population.https://t.co/banTov24VX pic.twitter.com/tLSZaUYXhw
— The Lancet (@TheLancet) January 6, 2022
Brief review: The clinician’s guide to p values, confidence intervals, and magnitude of effects.
28 Nov, 2021 | 21:06h | UTCThe clinician’s guide to p values, confidence intervals, and magnitude of effects – Eye (if the link is paywalled, try this one)
Related:
Bayesian interpretation of p values in clinical trials.
Scientists Rise Up Against Statistical Significance
.050 shades of grey in p-value cutoffs
What a nerdy debate about p-values shows about science — and how to fix it – VOX
Big names in statistics want to shake up much-maligned P value – Nature News
‘One-size-fits-all’ threshold for P values under fire – Nature News
Statisticians issue warning over misuse of P values – Nature News
Understanding common misconceptions about p-values – The 20% Statistician
Position Statement: Preoperative Care for Cataract Surgery – “In spite of evidence debunking the utility of testing before cataract surgery, studies suggest that medical testing and the use of medical consultations before cataract surgery continue to increase”.
17 Nov, 2021 | 08:33h | UTC
Commentary on Twitter
Nicely written position paper on preop care for cataract surgery. Addresses the most frequent questions (although actual study data is limited). Basically no tests, continue meds, and proceed in most cases unless recent MI,PCI,VTE,CVA,DKA, or HTN urgency. https://t.co/PLHm1LjhZg
— Steven Cohn, MD (@preopconsult) November 16, 2021
Degree of Myopia and Glaucoma Risk: A Dose-Response Meta-Analysis.
22 Oct, 2021 | 10:17h | UTC
Update and guidance on management of myopia.
26 Aug, 2021 | 08:35h | UTC
How to wear a mask and not fog up your glasses.
5 Aug, 2021 | 08:56h | UTCHow to wear a mask and not fog up your glasses – The Philadelphia Inquirer
Guideline summary: A Multidisciplinary collaborative approach to retinal toxic effects screening for patients taking antimalarials.
2 Aug, 2021 | 00:03h | UTCA Multidisciplinary Collaborative Approach to Retinal Toxic Effects Screening for Dermatology Patients Taking Antimalarials – JAMA Dermatology (free for a limited period)
Original Guidance: Joint Statement: Hydroxychloroquine use with respect to retinal toxicity
Clinical practice guidelines for the medical management of Graves’ orbitopathy.
26 Jul, 2021 | 02:26h | UTC
RCT: Intravitreal ranibizumab vs. aflibercept vs. bevacizumab for macular edema due to central retinal vein occlusion.
15 Jul, 2021 | 09:09h | UTC
Guideline | Hydroxychloroquine and Chloroquine Retinopathy: Recommendations on Monitoring.
6 Jul, 2021 | 10:03h | UTCExecutive summary: Hydroxychloroquine and Chloroquine Retinopathy: Recommendations on Monitoring – Royal College of Ophthalmologists
Review: Virtual consultation for red eye.
30 Jun, 2021 | 10:04h | UTCVirtual consultation for red eye – The BMJ
Commentary on Twitter
Red eye is a common ophthalmic presentation in primary care, accounting for 2 to 3% of the consultations.
How can you safely diagnose and manage patients with acute red eye(s) in a virtual consultation?https://t.co/cn12VYpyuW
— The BMJ (@bmj_latest) June 29, 2021
Pragmatic RCT: Among patients with advanced glaucoma, primary trabeculectomy resulted in similar quality of life and safety outcomes and achieved a lower intraocular pressure compared with primary medication.
17 May, 2021 | 08:06h | UTC
Update on Corneal Transplant in 2021
20 Apr, 2021 | 05:33h | UTCUpdate on Corneal Transplant in 2021 – JAMA (free for a limited period)
Study: Teprotumumab for patients with active thyroid eye disease
20 Apr, 2021 | 05:25h | UTCTeprotumumab for patients with active thyroid eye disease: a pooled data analysis, subgroup analyses, and off-treatment follow-up results from two randomised, double-masked, placebo-controlled, multicentre trials – The Lancet Diabetes & Endocrinology (link to abstract – $ for full-text)
Study suggests treatment not always needed to prevent vision loss in patients with elevated eye pressure
18 Apr, 2021 | 21:01h | UTCOriginal study: Assessment of Cumulative Incidence and Severity of Primary Open-Angle Glaucoma Among Participants in the Ocular Hypertension Treatment Study After 20 Years of Follow-up – JAMA Ophthalmology (free for a limited period)
Commentary on Twitter
Only 25% of the OHTS participants developed visual field loss over 20 years of follow-up https://t.co/2DV1gr0cbM
— JAMAOphthalmology (@JAMAOphth) April 15, 2021